Thompson Investment Management Inc. Buys 600 Shares of Colgate-Palmolive (NYSE:CL)

Thompson Investment Management Inc. grew its stake in shares of Colgate-Palmolive (NYSE:CL) by 19.7% in the fourth quarter, Holdings Channel reports. The fund owned 3,645 shares of the company’s stock after acquiring an additional 600 shares during the quarter. Thompson Investment Management Inc.’s holdings in Colgate-Palmolive were worth $331,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Chicago Partners Investment Group LLC lifted its position in shares of Colgate-Palmolive by 16.2% during the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after buying an additional 943 shares during the last quarter. Peak Financial Advisors LLC purchased a new stake in Colgate-Palmolive during the fourth quarter valued at about $1,315,000. Gordian Advisors LLC bought a new position in Colgate-Palmolive during the third quarter worth about $602,000. Carrera Capital Advisors increased its stake in shares of Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after purchasing an additional 7,353 shares in the last quarter. Finally, Fiduciary Alliance LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $4,066,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.3 %

Shares of CL stock opened at $86.81 on Monday. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The firm has a market cap of $70.93 billion, a P/E ratio of 24.66, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. The business has a 50-day moving average price of $90.36 and a two-hundred day moving average price of $96.77. Colgate-Palmolive has a 12-month low of $82.68 and a 12-month high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the company earned $0.87 earnings per share. Equities analysts anticipate that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on CL shares. Barclays reduced their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Piper Sandler dropped their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. UBS Group reduced their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Finally, TD Cowen lowered their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.